Cargando…

Prognostic Factors in the Survival of Patients Diagnosed with Primary Non-Metastatic Osteosarcoma with a Poor Response to Neoadjuvant Chemotherapy

INTRODUCTION: Identification of variables that determine the prognosis for osteosarcoma may enable stratification of patients into subgroups with better or worse risk of local recurrence, metastases and death due to the disease. Discovery of such prognostic factors would permit selection of a subgro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Júnior, Rosalvo Zósimo Bispo, de Camargo, Olavo Pires
Formato:	Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797586/ https://www.ncbi.nlm.nih.gov/pubmed/20037705 http://dx.doi.org/10.1590/S1807-59322009001200007

Ejemplares similares

IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?
por: Bispo Júnior, Rosalvo Zósimo, et al.
Publicado: (2015)

Prognostic Factors and Expression of MDM2 in Patients with Primary Extremity Liposarcoma
por: Júnior, Rosalvo Zósimo Bispo, et al.
Publicado: (2008)

Osteochondroma: ignore or investigate?()
por: de Souza, Antônio Marcelo Gonçalves, et al.
Publicado: (2014)

Chronic Multiple Knee Ligament Injuries: Epidemiological Analysis of More Than One Hundred Cases
por: Bispo, Rosalvo Zosimo, et al.
Publicado: (2008)

Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma
por: Erdoğan, Furkan, et al.
Publicado: (2023)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Correlation between the expression of vegf and survival in osteosarcoma
por: Baptista, André Mathias, et al.
Publicado: (2014)

Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
por: Robl, Bernhard, et al.
Publicado: (2015)

Translation and Transcultural Adaptation of the Milestones Instrument to Assess Teaching in Medical Residency Services on Orthopedics and Traumatology
por: Castro, Ubiratan Brum de, et al.
Publicado: (2022)

Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study
por: Prabowo, Yogi, et al.
Publicado: (2021)

Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer
por: Tobias, Claire J., et al.
Publicado: (2020)

Conventional osteosarcoma of the mandible successfully treated with radical surgery and adjuvant chemotherapy after responding poorly to neoadjuvant chemotherapy: a case report
por: Kimura, Yutaro, et al.
Publicado: (2017)

Development and validation of nomogram based on miR-203 and clinicopathological characteristics predicting survival after neoadjuvant chemotherapy and surgery for patients with non-metastatic osteosarcoma
por: Cheng, Dong, et al.
Publicado: (2017)

The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

SERUM VALUES OF ALKALINE PHOSPHATASE AND LACTATE DEHYDROGENASE IN OSTEOSARCOMA
por: ZUMÁRRAGA, JUAN PABLO, et al.
Publicado: (2016)

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes
por: Xu, Ming, et al.
Publicado: (2014)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

The prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy
por: Huang, Yujing, et al.
Publicado: (2016)

Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings
por: Liu, Chenglei, et al.
Publicado: (2019)

Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

PRIMARY LEIOMYOSARCOMA OF BONE: CLINICOPATHOLOGIC AND PROGNOSTIC FACTORS ANALYSIS IN A SINGLE INSTITUTION
por: Zumárraga, Juan Pablo, et al.
Publicado: (2019)

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
por: Oba, Takaaki, et al.
Publicado: (2020)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
por: Wu, Zhen-Jie, et al.
Publicado: (2018)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy
por: Xia, Xibin, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy and Expandable Prosthesis Reconstruction to Treat Osteosarcoma around the Knee in Children
por: Huang, Junqi, et al.
Publicado: (2022)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
por: Yong, Bicheng, et al.
Publicado: (2012)

Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
por: Bailly, Clement, et al.
Publicado: (2017)

Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T
por: Lee, Seul Ki, et al.
Publicado: (2020)

Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis
por: Baidya Kayal, Esha, et al.
Publicado: (2022)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy
por: Trieb, K, et al.
Publicado: (2000)

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
por: Guo, J, et al.
Publicado: (2015)

Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Prognostic Value of Radiological Response to Chemotherapy in Patients with Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2013)

Primary Osteosarcoma of the Urinary Bladder Metastatic to Lung
por: Elwy, Amira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jtmsm32lp3h6fh4cun7l04194n